Ashkin D - Search Results

1

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy.

Fishman JE, Saraf-Lavi E, Narita M, Hollender ES, Ramsinghani R, Ashkin D. Fishman JE, et al. Among authors: ashkin d. AJR Am J Roentgenol. 2000 Jan;174(1):43-9. doi: 10.2214/ajr.174.1.1740043. AJR Am J Roentgenol. 2000. PMID: 10628452

2

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.

Ungo JR, Jones D, Ashkin D, Hollender ES, Bernstein D, Albanese AP, Pitchenik AE. Ungo JR, et al. Among authors: ashkin d. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1871-6. doi: 10.1164/ajrccm.157.6.9711039. Am J Respir Crit Care Med. 1998. PMID: 9620920

3

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

Narita M, Ashkin D, Hollender ES, Pitchenik AE. Narita M, et al. Among authors: ashkin d. Am J Respir Crit Care Med. 1998 Jul;158(1):157-61. doi: 10.1164/ajrccm.158.1.9712001. Am J Respir Crit Care Med. 1998. PMID: 9655723

4

"Won't get fooled again" (by tuberculosis).

Ashkin D, Hollender ES, Narita M. Ashkin D, et al. Chest. 1999 Oct;116(4):856-7. doi: 10.1378/chest.116.4.856. Chest. 1999. PMID: 10531141 No abstract available.

5

Mesothelial cells in tuberculous pleural effusions of HIV-infected patients.

Jones D, Lieb T, Narita M, Hollender ES, Pitchenik AE, Ashkin D. Jones D, et al. Among authors: ashkin d. Chest. 2000 Jan;117(1):289-91. doi: 10.1378/chest.117.1.289. Chest. 2000. PMID: 10631236

6

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis.

Narita M, Stambaugh JJ, Hollender ES, Jones D, Pitchenik AE, Ashkin D. Narita M, et al. Among authors: ashkin d. Clin Infect Dis. 2000 May;30(5):779-83. doi: 10.1086/313771. Epub 2000 Apr 28. Clin Infect Dis. 2000. PMID: 10816148 Clinical Trial.

7

Tuberculosis recurrence: multivariate analysis of serum levels of tuberculosis drugs, human immunodeficiency virus status, and other risk factors.

Narita M, Hisada M, Thimmappa B, Stambaugh J, Ibrahim E, Hollender E, Ashkin D. Narita M, et al. Among authors: ashkin d. Clin Infect Dis. 2001 Feb 1;32(3):515-7. doi: 10.1086/318490. Epub 2001 Jan 25. Clin Infect Dis. 2001. PMID: 11170964

8

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

Narita M, Alonso P, Lauzardo M, Hollender ES, Pitchenik AE, Ashkin D. Narita M, et al. Among authors: ashkin d. Chest. 2001 Aug;120(2):343-8. doi: 10.1378/chest.120.2.343. Chest. 2001. PMID: 11502627

9

Who dunnit? The changing face of tuberculosis control utilizing restriction fragment length polymorphism.

Lauzardo M, Hollender ES, Narita M, Ashkin D. Lauzardo M, et al. Among authors: ashkin d. Chest. 2001 Dec;120(6):1765-8. doi: 10.1378/chest.120.6.1765. Chest. 2001. PMID: 11742897 No abstract available.

10

Ofloxacin population pharmacokinetics in patients with tuberculosis.

Stambaugh JJ, Berning SE, Bulpitt AE, Hollender ES, Narita M, Ashkin D, Peloquin CA. Stambaugh JJ, et al. Among authors: ashkin d. Int J Tuberc Lung Dis. 2002 Jun;6(6):503-9. doi: 10.5588/09640569513011. Int J Tuberc Lung Dis. 2002. PMID: 12068983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page